Published in Lancet on October 23, 1999
Epigenesis of behavioural lateralization in humans and other animals. Philos Trans R Soc Lond B Biol Sci (2009) 1.09
Origins of handedness: a nationwide study of 30,161 adults. Neuropsychologia (2009) 1.01
KCNQ1 and KCNE1 K+ channel components are involved in early left-right patterning in Xenopus laevis embryos. Cell Physiol Biochem (2008) 1.00
The epigenesis of planum temporale asymmetry in twins. Cereb Cortex (2002) 0.92
Crossed cerebral lateralization for verbal and visuo-spatial function in a pair of handedness discordant monozygotic twins: MRI and fMRI brain imaging. J Anat (2008) 0.92
Cerebellar asymmetry in a pair of monozygotic handedness-discordant twins. J Anat (2010) 0.80
Mirror-image arachnoid cysts in a pair of monozygotic twins: a case report and review of the literature. Int J Med Sci (2011) 0.78
An overview of human handedness in twins. Front Psychol (2014) 0.77
Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry (1991) 5.36
Memory impairment in schizophrenia: a meta-analysis. Am J Psychiatry (1999) 3.69
CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy. Mol Psychiatry (2007) 3.44
Handedness, language lateralisation and anatomical asymmetry in schizophrenia: meta-analysis. Br J Psychiatry (2001) 2.74
Nobel laureates' letter to President Bush. Washington Post (2001) 2.43
Quantitative genetic modeling of variation in human brain morphology. Cereb Cortex (2001) 2.24
[Functional imaging of the brain in the investigation of chronic unexplained pain]. Ned Tijdschr Geneeskd (2007) 2.02
Acute dystonia induced by drug treatment. BMJ (1999) 1.71
First contact incidence of psychotic disorders among native Dutch and Moroccan immigrants in the Netherlands: influence of diagnostic bias. Schizophr Res (2010) 1.68
Catatonia: disappeared or under-diagnosed? Psychopathology (2005) 1.64
Functional anatomical correlates of controlled and automatic processing. J Cogn Neurosci (2001) 1.60
Structural brain abnormalities in patients with schizophrenia and their healthy siblings. Am J Psychiatry (2000) 1.55
Intermittent neuroleptic treatment and risk for tardive dyskinesia: Curaçao Extrapyramidal Syndromes Study III. Am J Psychiatry (1998) 1.55
Functional magnetic resonance imaging brain mapping in psychiatry: methodological issues illustrated in a study of working memory in schizophrenia. Neuropsychopharmacology (1998) 1.54
Multivariate genetic analysis of brain structure in an extended twin design. Behav Genet (2000) 1.49
Differential effects of DRD4 and DAT1 genotype on fronto-striatal gray matter volumes in a sample of subjects with attention deficit hyperactivity disorder, their unaffected siblings, and controls. Mol Psychiatry (2005) 1.49
Outcome of schizophrenia in relation to brain abnormalities. Schizophr Bull (1999) 1.46
Relapse prevention in major depressive disorder after successful ECT: a literature review and a naturalistic case series. Acta Psychiatr Scand (2000) 1.45
Language lateralization in schizophrenia, an fMRI study. Schizophr Res (2001) 1.41
Effects of neuroleptic treatment on symptoms of schizophrenia and plasma homovanillic acid concentrations. Arch Gen Psychiatry (1991) 1.41
An association screen of myelin-related genes implicates the chromosome 22q11 PIK4CA gene in schizophrenia. Mol Psychiatry (2007) 1.38
[Psyche, psychiatric and 'psycho-']. Tijdschr Psychiatr (2016) 1.38
Fluoxetine treatment of slow eating. J Clin Psychiatry (1992) 1.37
Test-retest reliability of fMRI activation during prosaccades and antisaccades. Neuroimage (2007) 1.36
Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users. Psychol Med (2007) 1.34
Specific versus nonspecific brain activity in a parametric N-back task. Neuroimage (2000) 1.32
Schizophrenia in Surinamese and Dutch Antillean immigrants to The Netherlands: evidence of an increased incidence. Psychol Med (1997) 1.31
Design and analysis of small-scale transmission experiments with animals. Epidemiol Infect (2007) 1.30
Meta-analysis of repetitive transcranial magnetic stimulation in the treatment of auditory verbal hallucinations: update and effects after one month. Schizophr Res (2012) 1.29
Reproducibility of fMRI-determined language lateralization in individual subjects. Brain Lang (2002) 1.27
Focal gray matter density changes in schizophrenia. Arch Gen Psychiatry (2001) 1.27
Health care reform and the special needs of children. Pediatrics (1994) 1.25
Brain volume changes in the first year of illness and 5-year outcome of schizophrenia. Br J Psychiatry (2006) 1.23
Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis. Mol Psychiatry (2006) 1.23
Does the Schizotypal Personality Questionnaire reflect the biological-genetic vulnerability to schizophrenia? Schizophr Res (2002) 1.23
[A bifid uvula in a patient with schizophrenia as a sign of 22q11 deletion syndrome]. Ned Tijdschr Geneeskd (2002) 1.22
Denosologization of biological psychiatry or the specificity of 5-HT disturbances in psychiatric disorders. J Affect Disord (1987) 1.22
Development of a functional magnetic resonance imaging protocol for intraoperative localization of critical temporoparietal language areas. Ann Neurol (2002) 1.20
Prenatal exposure to famine and brain morphology in schizophrenia. Am J Psychiatry (2000) 1.19
Risk factors for the introduction of high pathogenicity Avian Influenza virus into poultry farms during the epidemic in the Netherlands in 2003. Prev Vet Med (2005) 1.19
Working memory capacity in schizophrenia: a parametric fMRI study. Schizophr Res (2004) 1.19
Region and state specific glutamate downregulation in major depressive disorder: a meta-analysis of (1)H-MRS findings. Neurosci Biobehav Rev (2011) 1.18
New perspectives in the diagnosis of hepatitis C. Semin Liver Dis (1999) 1.18
Exercise therapy improves mental and physical health in schizophrenia: a randomised controlled trial. Acta Psychiatr Scand (2012) 1.17
Volumetric analysis of frontal lobe regions in schizophrenia: relation to cognitive function and symptomatology. Biol Psychiatry (1999) 1.14
Brain MRI abnormalities in schizophrenia: same genes or same environment? Psychol Med (2005) 1.14
Contribution of residential exposures to asthma in us children and adolescents. Pediatrics (2001) 1.14
Volumes of brain structures in twins discordant for schizophrenia. Arch Gen Psychiatry (2001) 1.14
Investigating gene environment interaction in complex diseases: increasing power by selective sampling for environmental exposure. Int J Epidemiol (2007) 1.13
FMRI-determined language lateralization in patients with unilateral or mixed language dominance according to the Wada test. Neuroimage (2002) 1.12
Interactions between ego- and allocentric neuronal representations of space. Neuroimage (2006) 1.12
Childhood trauma and auditory verbal hallucinations. Psychol Med (2012) 1.11
Epigenesis of behavioural lateralization in humans and other animals. Philos Trans R Soc Lond B Biol Sci (2009) 1.09
Statistical analysis of functional MRI data in the wavelet domain. IEEE Trans Med Imaging (1998) 1.08
Development of a classical swine fever subunit marker vaccine and companion diagnostic test. Vet Microbiol (2000) 1.07
Treatment with clozapine and its effect on plasma homovanillic acid and norepinephrine concentrations in schizophrenia. Psychiatry Res (1993) 1.07
Combined analysis of language tasks in fMRI improves assessment of hemispheric dominance for language functions in individual subjects. Neuroimage (2001) 1.07
Olanzapine and haloperidol in first episode psychosis: two-year data. Schizophr Res (2006) 1.07
Tardive dystonia. Schizophr Bull (1999) 1.07
Language lateralization in monozygotic twin pairs concordant and discordant for handedness. Brain (2002) 1.05
The effects of a sub-anaesthetic dose of ketamine on human selective attention. Neuropsychopharmacology (2000) 1.05
The effect of inoculation dose of a highly pathogenic avian influenza virus strain H5N1 on the infectiousness of chickens. Vet Microbiol (2010) 1.04
Reviewing the role of the genes G72 and DAAO in glutamate neurotransmission in schizophrenia. Eur Neuropsychopharmacol (2007) 1.03
Quantifying transmission of Campylobacter spp. among broilers. Appl Environ Microbiol (2005) 1.03
Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Mol Psychiatry (2015) 1.03
The role of backyard poultry flocks in the epidemic of highly pathogenic avian influenza virus (H7N7) in the Netherlands in 2003. Prev Vet Med (2009) 1.03
Endogenous opioids and reward. Eur J Pharmacol (2000) 1.03
fMRI study of effort and information processing in a working memory task. Hum Brain Mapp (2007) 1.03
African swine fever virus excretion patterns in persistently infected animals: a quantitative approach. Vet Microbiol (2012) 1.02
The prevalence of tardive dystonia, tardive dyskinesia, parkinsonism and akathisia The Curaçao Extrapyramidal Syndromes Study: I. Schizophr Res (1996) 1.01
Language lateralization in female patients with schizophrenia: an fMRI study. Schizophr Res (2003) 1.01
Test-retest variability underlying fMRI measurements. Neuroimage (2011) 1.00
Selective impairments in the stress response in schizophrenic patients. Psychopharmacology (Berl) (2000) 1.00
The PIP5K2A and RGS4 genes are differentially associated with deficit and non-deficit schizophrenia. Genes Brain Behav (2007) 0.99
Microstructural alterations of the arcuate fasciculus in schizophrenia patients with frequent auditory verbal hallucinations. Schizophr Res (2011) 0.99
Psychosis and brain volume changes during the first five years of schizophrenia. Eur Neuropsychopharmacol (2008) 0.99
Depression in Parkinson's disease. The impact of symptom overlap on prevalence. Psychosomatics (1998) 0.99
A stereotactic method for image-guided transcranial magnetic stimulation validated with fMRI and motor-evoked potentials. Neuroimage (2004) 0.98
Neuregulin 1: genetic support for schizophrenia subtypes. Mol Psychiatry (2004) 0.98
Maternal depression, child behavior, and injury. Inj Prev (2007) 0.97
Experimental non-transmissible marker vaccines for classical swine fever (CSF) by trans-complementation of E(rns) or E2 of CSFV. Vaccine (2002) 0.97
Partial volume decrease of the thalamus in relatives of patients with schizophrenia. Am J Psychiatry (1998) 0.96
The effects of low dose ketamine on sensory gating, neuroendocrine secretion and behavior in healthy human subjects. Psychopharmacology (Berl) (1998) 0.96
Genetic influences on thinning of the cerebral cortex during development. Neuroimage (2011) 0.96
Blunted cortisol response to a psychosocial stressor in schizophrenia. Schizophr Res (1998) 0.96
A decision-tree to optimise control measures during the early stage of a foot-and-mouth disease epidemic. Prev Vet Med (2002) 0.96
Serological and mucosal immune responses after vaccination and infection with FMDV in pigs. Vaccine (2006) 0.96
Herd immunity after vaccination: how to quantify it and how to use it to halt disease. Vaccine (2001) 0.95
A double hit implicates DIAPH3 as an autism risk gene. Mol Psychiatry (2010) 0.95
Network analysis of positional candidate genes of schizophrenia highlights myelin-related pathways. Mol Psychiatry (2009) 0.95